Infectious Vaccine Collaboration, Development, Research and Licensing Deals Trends Report 2024 with Directory of 522 Agreements Signed Since 2019
May 07, 2024 06:37 ET
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Infectious Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Infectious Vaccine...
599 Cancer Monoclonal Antibody Collaboration and Licensing Deals Report and Directory 2016-2024
May 07, 2024 06:35 ET
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Cancer Monoclonal...
Drug Delivery Collaboration, Development, Research and Licensing Deals Analysis Report 2024 with Directory of 1,666 Agreements Signed Since 2019
May 07, 2024 06:33 ET
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Drug Delivery Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Drug Delivery Collaboration and...
Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
May 07, 2024 06:30 ET
|
Design Therapeutics, Inc.
CARLSBAD, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for serious degenerative genetic diseases, today announced...
97% of Organizations Hit by Ransomware Worked with Law Enforcement, Sophos State of Ransomware Report Finds
May 07, 2024 06:30 ET
|
Sophos Inc.
OXFORD, United Kingdom, May 07, 2024 (GLOBE NEWSWIRE) -- Sophos, a global leader of innovative security solutions that defeat cyberattacks, today released additional findings from its annual “State...
Vivid Seats Delivers Strong First Quarter Results
May 07, 2024 06:30 ET
|
Vivid Seats LLC
CHICAGO, May 07, 2024 (GLOBE NEWSWIRE) -- Vivid Seats Inc. (NASDAQ: SEAT) (“Vivid Seats” or “we”), a leading marketplace that utilizes its technology platform to connect millions of buyers with...
Beam Therapeutics Reports Pipeline Updates and First Quarter 2024 Financial Results
May 07, 2024 06:30 ET
|
Beam Therapeutics
Dosing Completed for Sentinel Cohort of BEACON Phase 1/2 Trial of BEAM-101 in Severe Sickle Cell Disease; Expansion Cohort Initiated Clinical Trial Authorisation (CTA) Application Cleared for the...
Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma
May 07, 2024 06:30 ET
|
Connect Biopharma Holdings Limited
SAN DIEGO, CA and TAICANG, China, May 07, 2024 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmaceutical...
Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH
May 07, 2024 06:30 ET
|
Teleflex Incorporated
WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, today announced the presentation of new research findings from the 2024...
RAN Intelligent Controller Market to Grow at CAGR of 59.4% through 2033 - Rising Demand for Network Virtualization to Bolster Growth
May 07, 2024 06:30 ET
|
The Brainy Insights
Newark, May 07, 2024 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the global RAN intelligent controller market will grow from USD 349.45 Million in 2023 to USD 37,005.94 Million by 2033....